Identification of L-ferritin in neuromelanin granules of the human substantia nigra: A targeted proteomics approach

Molecular and Cellular Proteomics

Volumn 8, Issue 8, 2009, Pages 1832-1838

  Tribl, Florian ^a,b   Asan, Esther ^c   Arzberger, Thomas ^d   Tatschner, Thomas ^c   Langenfeld, Elmar ^b   Meyer, Helmut E ^b   Bringmann, Gerhard ^c   Riederer, Peter ^a   Gerlach, Manfred ^a,c   Marcus, Katrin ^e  

^a National Parkinson Foundation   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e Julius Maximilians Universität Würzburg ^*

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FERRITIN; IRON; L FERRITIN; NEUROMELANIN; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL FRACTIONATION; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; ELECTROSPRAY MASS SPECTROMETRY; GRANULE CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGOLD LABELING; LIQUID CHROMATOGRAPHY; MOSSBAUER SPECTROSCOPY; NERVE CELL; NERVE CELL NETWORK; NEUROECTODERM; NUCLEOTIDE SEQUENCE; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; ROENTGEN SPECTROSCOPY; SUBSTANTIA NIGRA; TANDEM MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

APOFERRITINS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOPLASMIC GRANULES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MELANINS; MICROSCOPY, IMMUNOELECTRON; POSTMORTEM CHANGES; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANTIA NIGRA;

EID: 71049137290     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M900006-MCP200     Document Type: Article

References (46)

1. Fedorow, H., Tribl, F., Halliday, G., Gerlach, M., Riederer, P., and Double, K. L. (2005) Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Prog. Neurobiol. 75, 109-124
2. Hirsch, E., Graybiel, A. M., and Agid, Y. A. (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334, 345-348 (Pubitemid 18177660)
3. Kastner, A., Hirsch, E. C., Lejeune, O., Javoy-Agid, F., Rascol, O., and Agid, Y. (1992) Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J. Neureichem. 59, 1080-1089
4. Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben-Shachar, D., and Youdim, M. B. (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis. J. Neurochem. 59, 1168-1171
5. Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., and Tampellini, D. (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J. Neurochem. 76, 1766-1773 (Pubitemid 32221116)
6. Aime, S., Bergamasco, B., Biglino, D., Digilio, G., Fasano, M., Giamello, E., and Lopiano, L. (1997) EPR investigations of the iron domain in neuromelanin. Biochim. Biophys. Acta 1361, 49-58
7. Fasano, M., Bergamasco, B., and Lopiano, L. (2006) Modifications of the iron-neuromelanin system in Parkinson's disease. J. Neurochem. 96, 909-916
8. Double, K. L., Ben-Shachar, D., Youdim, M. B., Zecca, L., Riederer, P., and Gerlach, M. (2002) Influence of neuromelanin on oxidative pathways within the human substantia nigra. Neurotoxicol. Teratol. 24, 621-628
9. Gerlach, M., Ben-Shachar, D., Riederer, P., and Youdim, M. B. (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63, 793-807 (Pubitemid 24266591)
10. Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R., and Crichton, R. R. (2004) Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863-873
11. Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., and Youdim, M. B. (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 74, 199-205
12. Riederer, P., Sofic, E., Rausch, W. D., Schmidt, B., Reynolds, G. P., Jellinger, K., and Youdim, M. B. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520
13. Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., and Youdim, M. B. (1990) Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Transm. Park. Dis. Dement. Sect. 2, 327-340
14. Berg, D., Gerlach, M., Youdim, M. B., Double, K. L., Zecca, L., Riederer, P., and Becker, G. (2001) Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 79, 225-236 (Pubitemid 32988938)
15. Connor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., and LeWitt, P. (1995) A quantitative analysis of isofem'tins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65, 717-724
16. Zecca, L., and Swartz, H. M. (1993) Total and paramagnetic metals in human substantia nigra and its neuromelanin. J. Neural Transm. Park. Dis. Dement. Sect. 5, 203-213
17. Zecca, L., Mecacci, C., Seraglia, R., and Parati, E. (1992) The chemical characterization of melanin contained in substantia nigra of human brain. Biochim. Biophys. Acta 1138, 6-10
18. Double, K. L., Gerlach, M., Schünemann, V., Trautwein, A. X., Zecca, L., Gallorini, M., Youdim, M. B., Riederer, P., and Ben-Shachar, D. (2003) Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem. Pharmacol. 66, 489-494
19. Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., and Swartz, H. M. (1996) Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neuroscience 73, 407-415 (Pubitemid 26169932)
20. Kienzl, E., Puchinger, L., Jellinger, K., Linert, W., Stachelberger, H., and Jameson, R. F. (1995) The role of transition metals in the pathogenesis of Parkinson's disease. J. Neurol. Sci. 134, 69-78
21. Gerlach, M., Trautwein, A. X., Zecca, L., Youdim, M. B., and Riederer, P. (1995) Mossbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra. J. Neurochem. 65, 923-926
22. Bohic, S., Murphy, K., Paulus, W., Cloetens, P., Salome, M., Susini, J., and Double, K. (2008) Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron x-ray microspectroscopy. Anal. Chem. 80, 9557-9566
23. Connor, J. R. (2003) Iron transport proteins in the diseased brain. J. Neurol. Sci. 207, 112-113
24. Tribl, F., Gerlach, M., Marcus, K., Asan, E., Tatschner, T., Arzberger, T., Meyer, H. E., Bringmann, G., and Riederer, P. (2005) "Subcellular proteomics" of neuromelanin granules isolated from the human brain. Mol. Cell. Proteomics 4, 945-957
25. Tribl, F., Marcus, K., Meyer, H. E., Bringmann, G., Gerlach, M., and Riederer, P. (2006) Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle. J. Neural Transm. 113, 741-749
26. Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K., Krek, W., Aebersold, R., and Domon, B. (2007) High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell. Proteomics 6, 1809-1817
27. Domon, B., and Aebersold, R. (2006) Mass spectrometry and protein analysis. Science 312, 212-217
28. Lehmann, U., Wienkoop, S., Tschoep, H., and Weckwerth, W. (2008) If the antibody fails - a mass Western approach. Plant J. 55, 1039-1046
29. Tribl, F., Meyer, H. E., and Marcus, K. (2008) Analysis of organelles within the nervous system: impact on brain and organelle functions. Expert Rev. Proteomics 5, 333-351 (Pubitemid 351670935)
30. Tribl, F., Marcus, K., Bringmann, G., Meyer, H. E., Gerlach, M., and Riederer, P. (2006) Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity. J. Neural Transm. 113, 1041-1054
31. Harrison, P. M., and Arosio, P. (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161-203
32. Connor, J. R., Menzies, S. L., Burdo, J. R., and Boyer, P. J. (2001) Iron and iron management proteins in neurobiology. Pediatr. Neurol. 25, 118-129
33. Youdim, M. B., Ben-Shachar, D., and Riederer, P. (1994) The enigma of neuromelanin in Parkinson's disease substantia nigra. J. Neural Transm. Suppl. 43, 113-122
34. Maresca, V., Flori, E., Cardinali, G., Briganti, S., Lombardi, D., Mileo, A. M., Paggi, M. G., and Picardo, M. (2006) Ferritin light chain down-modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation. J. Cell. Physiol. 206, 843-848
35. Palumbo, A., d'Ischia, M., Misuraca, G., Carratú, L., and Prota, G. (1990) Activation of mammalian tyrosinase by ferrous ions. Biochim. Biophys. Acta 1033, 256-260
36. Ikemoto, K., Nagatsu, I., Ito, S., King, R. A., Nishimura, A., and Nagatsu, T. (1998) Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? Neurosci Lett. 253, 198-200
37. Foley, J. M., and Baxter, D. (1958) On the nature of pigment granules in the cells of the locus coeruleus and substantia nigra. J. Neuropathol. Exp. Neurol. 17, 586-598
38. Marsden, C. D. (1961) Tyrosinase activity in the pigmented cells of the nucleus substantiae nigrae. Q. J. Microsc. Sci. 102, 469-474
39. Jeon, B. S. (1997) Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency. J. Korean Med. Sci. 12, 269-279
40. Bandmann, O., and Wood, N. W. (2002) Dopa-responsive dystona - the story so far. Neuropediatrics 33, 1-5
41. Jellinger, K. A. (2003) Rett Syndrome - an update. J. Neural Transm. 110, 681-701
42. Kemppainen, N., Röyttä, M., Collan, Y., Ma, S. Y., Hinkka, S., and Rinne, J. O. (2002) Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's disease. Acta Neuropathol. 103, 43-47 (Pubitemid 36075311)
43. Reyes, M. G., Faraldi, F., Rydman, R., and Wang, C. C. (2003) Decreased nigral neuromelanin in Alzheimer's disease. Neurol. Res. 25, 179-182
44. Aime, S., Bergamasco, B., Casu, M., Digilio, G., Fasano, M., Giraudo, S., and Lopiano, L. (2000) Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease. Mov. Disord. 15, 977-981
45. Fasano, M., Bergamasco, B., and Lopiano, L. (2006) Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies. J. Neural Transm. 113, 769-774 (Pubitemid 43847170)
46. Bolzoni, F., Giraudo, S., Lopiano, L., Bergamasco, B., Fasano, M., and Crippa, P. R. (2002) Magnetic investigations of human mesencephalic neuromelanin. Biochim. Biophys. Acta 1586, 210-218